PHARMACOVIGILANCE IN THE CONTEXT OF COVID-19 IN HEALTH PROFESSIONALS OF THE PERUVIAN SOCIAL INSURANCE

被引:1
|
作者
Rodriguez-Tanta, L. Yesenia [1 ]
Ale-Mauricio, Diego Andre [2 ]
Saromo-Melendez, Violeta [1 ]
Lazarte-Ramos, Anais [1 ]
Galvez-Davila, Elisa [1 ]
Pecho-Arias, Gisela [1 ]
Urruchi-Huertas, Jack [1 ]
Fernandez-Rojas, Paola [1 ]
Delgado-Escalante, Raquel [1 ]
机构
[1] Inst Evaluac Tecnol Salud & Invest, EsSalud, Lima, Peru
[2] Inst Nacl Salud, Lima, Peru
来源
REVISTA PERUANA DE MEDICINA EXPERIMENTAL Y SALUD PUBLICA | 2022年 / 39卷 / 01期
关键词
Drug Safety; Pharmacovigilance; Health Knowledge; Attitudes; Practice; Healthcare Wor-; kers; COVID-19 (source: MeSH NLM); CARE PROFESSIONALS; HOSPITALS; KNOWLEDGE; ATTITUDE;
D O I
10.17843/rpmesp.2022.391.10651
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The study aimed to evaluate a group of health professionals' knowledge, attitudes, and practices on pharmacovigilance in the context of COVID-19 in the Peruvian Social Health Insurance (EsSalud). A descriptive secondary analysis was carried out on a database that included responses from an online survey conducted by the Institutional Referral Center for Pharmacovigilance and Technovigilance of EsSalud. Of 144 participants, 66% showed a high level of knowledge and 81.2% had a positive attitude; however, 71.5% had an inadequate level of pharmacovigilance practice. Although EsSalud professionals demonstrated a high level of knowledge and positive attitude to implement pharmacovigilance, this is not reflected in the practice of this activity during the SARS-CoV-2 pandemic. Strategies should be implemented to integrate pharmacovigilance into healthcare activities to benefit patient safety.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [21] The roles of social norms and leadership in health communication in the context of COVID-19
    Akfirat, Serap
    Bayrak, Fatih
    Uzumceker, Emir
    Ergiyen, Tolga
    Yurtbakan, Taylan
    Uysal, Mete Sefa
    SOCIAL SCIENCE & MEDICINE, 2023, 323
  • [22] Correct Use of Facemask Among Health Professionals in the Context of Coronavirus Disease (COVID-19)
    Tekalegn, Yohannes
    Sahiledengle, Biniyam
    Bekele, Kebebe
    Tesemma, Abdi
    Aseffa, Tesfaye
    Engida, Zinash Teferu
    Girma, Alemu
    Tasew, Alelign
    Zenbaba, Demisu
    Aman, Rameto
    Seyoum, Kenbon
    Woldeyohannes, Demelash
    Legese, Birhan
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2020, 13 : 3013 - 3019
  • [23] How Mental Health Professionals Can Address Disparities in the Context of the COVID-19 Pandemic
    Loeb, Tamra B.
    Ebor, Megan T.
    Smith, Amber M.
    Chin, Dorothy
    Novacek, Derek M.
    Hampton-Anderson, Joya N.
    Norwood-Scott, Enricka
    Hamilton, Alison B.
    Brown, Arleen F.
    Wyatt, Gail E.
    TRAUMATOLOGY, 2021, 27 (01) : 60 - 69
  • [24] High time to stop workplace violence against health professionals in the context of COVID-19
    Xiao, Yu
    Du, Na
    Chen, Ting-Ting
    Cheng, Hao-Fei
    FAMILY PRACTICE, 2022, 41 (04) : 393 - 394
  • [25] ORGANIZATIONAL COMMITMENT OF HEALTH PROFESSIONALS TO COVID-19
    Bernal Gonzalez, Idolina
    Ruiz Mezquiti, Laura Alejandra
    Pastrana Zuniga, Jorge Luis
    REVISTA UNIVERSIDAD Y SOCIEDAD, 2021, 13 (06): : 194 - 204
  • [26] Health professionals fight against COVID-19
    Servolo Medeiros, Eduardo Alexandrino
    ACTA PAULISTA DE ENFERMAGEM, 2020, 33
  • [27] COVID-19 and the occupational stress experienced by health professionals in the hospital context: integrative review
    Goncalves Costa, Natali Nascimento
    Silva Servo, Maria Lucia
    Figueredo, Wilton Nascimento
    REVISTA BRASILEIRA DE ENFERMAGEM, 2022, 75
  • [28] Covid-19 and health insurance reform in Azerbaijan
    Guliyev, Farid
    GLOBAL SOCIAL POLICY, 2023, 23 (02) : 360 - 363
  • [29] COVID-19 and the US health insurance conundrum
    不详
    LANCET ONCOLOGY, 2020, 21 (06): : 733 - 733
  • [30] Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
    Grandvuillemin, Aurelie
    Rocher, Fanny
    Valnet-Rabier, Marie Blanche
    Drici, Milou-Daniel
    French Pharmacovigilance Network
    THERAPIE, 2023, 78 (05): : 523 - 529